Status
Conditions
Treatments
About
The objective of the study is to verify the efficacies of both air and saline based procedure of EpiFaith syringe for assisting the needle localization of the epidural space.
Full description
This is a single blind, randomized study. Subjects who will receive a surgery requiring epidural anesthesia or analgesia and meet all of the study criteria will be enrolled in the study. All subjects must sign an informed consent and receive a copy of the signed and dated informed consent form prior to participation in the trial.
The study consists of 2 study visits: Visit 1 (Screening Visit) and Visit 2 (Operative Visit). After screening, eligible subject will be randomly assigned to one of the following groups: Group A: detection by EpiFaith syringe with air; Group S: detection by EpiFaith syringe with saline with a 1:1 ratio. In Visit 2, the following variables will be recorded and rated during the process of epidural space localization: Success of epidural localization, time to identify the epidural space, duration of the epidural space localization procedure, number of attempts, Number of the occurrence of false positive, the distance from the skin to the epidural space, and number of change insertion segment. Adverse events and concomitant treatments will be also recorded.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Bleeding and clotting disorders
History of peripheral neuropathy
Neuromuscular or neuropsychiatric disease
Marked spinal deformities or a history of spinal instrumentation
Systemic infection
Skin infection at the injection site
Significant heart failure, e.g. New York Heart Association (NYHA) Functional Classification 3 or 4
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
Chien-Kun Ting, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal